Related Funds
Fund Name | Location |
Axis Capital | India, Maharashtra, Mumbai |
Candou Ventures | California, Palo Alto, United States |
Chip One Stop | Japan, Kanagawa Prefecture, Yokohama |
CMG-SDIC Capital Management | Beijing, Beijing, China |
Coagulare Biomedica | - |
Commerce.Asia | Kuala Lumpur, Malaysia |
Eminence Capital LP | New York, New York, United States |
Hitachi Global Life Solutions | Japan, Shibuya |
Ironfire Ventures | China, Hong Kong, Hong Kong Island |
Jianmin Pharmaceuticals | - |
JWEI | China, Jiangsu, Nanjing |
Mirrabooka Investments | - |
Schibsted | Norway, Oslo |
Shinsegae I&C | - |
Spangler Financial Group | - |
SPF Investment Management | New York, New York, United States |
Tianshiyun Jiaoyu | Beijing, China, Haidian |
University of Pittsburgh Innovation Institute | Pennsylvania, Pittsburgh, United States |
Wonderful Sky Financial Group | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
EyeControl | $7M | 12 Aug 2020 | Tel Aviv-Yafo, Tel Aviv District, Israel | ||
Biobeat | $8M | 01 Mar 2020 | Israel, North District |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
EyeControl | $7M | 12 Aug 2020 | Tel Aviv-Yafo, Tel Aviv District, Israel | ||
Biobeat | $8M | 01 Mar 2020 | Israel, North District |